Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)

PHASE3CompletedINTERVENTIONAL
Enrollment

10,214

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

July 27, 2022

Conditions
COVID-19
Interventions
BIOLOGICAL

CoronaVac

Two doses at 14-day interval, each inoculation dose is 0.5 mL. Two doses of dosage (each prefilled syringe of the vaccine contains 600 SU of SARS-CoV-2 virus antigen) experimental vaccine at the schedule of day 0,14

BIOLOGICAL

Placebo

Aluminium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, sodium chloride 0.5mL/dose, two doses given 14 days apart.

Trial Locations (25)

06800

T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara

T.R. Ministry of Health Ankara Provincial Health Directorate Ankara Training and Research Hospital, Infectious Diseases, Ankara

Unknown

Ankara University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara

Çukurova University Faculty of Medicine, Department of Infectious Diseases, Adana

Hacettepe University Faculty of Medicine Department of Infections Diseases and Clinical Microbiology, Ankara

T.C Ministry of Health Ankara Provincial Health Directorate Health Sciences University Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara

Akdeniz University Faculty of Medicine, Department of Infectious Diseases, Antalya

Bursa Uludağ University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bursa

Dicle University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Diyarbakır

Gaziantep University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Gaziantep

Acıbadem Atakent Hospital, Infectious Diseases and Clinical Microbiology, Istanbul

Cerrahpaşa Faculty of Medicine, Department of Internal Medicine - Department of Infectious Diseases and Clinical Microbiology, Istanbul

Istanbul Medipol University Faculty of Medicine, Department of Internal Medicine, Istanbul

Istanbul University Istanbul Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul

T.R. Ministry of Health Istanbul Provincial Health Directorate Marmara Univesity Istanbul Pendik Education and Research Hospital, Istanbul

T.R. Ministry of Health Istanbul Provincial Health Directorate Prof. Dr. Cemil Taşçıoğlu City Hospital, Infectious Diseases Clinic, Istanbul

T.R. Ministry of Health Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul

University of Health Sciences İstanbul Ümraniye Training and Research Hospital, Istanbul

Ege University Faculty of Medicine Hospital, Department of Infectious Diseasesaculty of Medicine Hospital, Department of Infectious Diseases, Izmir

Republic Of Turkey Ministry Of Health Izmir Provincial Health Directorate Health Sciences University Dr Suat Seren Chest Diseases And Chest Surgery Training And Research Hospital, Izmir

T.R. Ministry of Health İzmir Provincial Health Directorate İzmir Health Sciences University Tepecik Training and Research Hospital, Infectious Diseases, Izmir

T.R. Ministry of Health Kayseri City Training and Research Hospital, Infectious Diseases and Clinical Microbiology Department, Kayseri

Kocaeli University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Kocaeli

Malatya İnönü University Faculty of Medicine, Department of Infectious Diseases, Malatya

Karadeniz Technical University Medical Faculty Hospital, Department of Infectious Diseases and Clinical Microbiology, Trabzon

All Listed Sponsors
lead

Health Institutes of Turkey

OTHER_GOV

NCT04582344 - Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) | Biotech Hunter | Biotech Hunter